| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 3e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 6e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.28 | 0.0001 |